Participants 116 154 7
advanced head and neck cancer patients
Participants 498 565 4
first-line treatment of patients with advanced head and neck cancer
Participants 587 763 6
successive patients with unresectable grade I/II head and neck cancer who were not suitable for irradiation treatment (T any N3 or T4 N2C), metastatic or previously irradiated.
Participants 888 938 7
A total of 170 patients were included in the study
Participants 3183 3215 4
in head and neck cancer patients
